BWX Technologies Total Cost of Revenue decreased by 5.1% to $662.85M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 28.2%, from $517.07M to $662.85M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 11.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $375.82M | $361.53M | $443.64M | $404.83M | $413.00M | $399.28M | $463.79M | $431.13M | $471.32M | $436.30M | $536.97M | $455.36M | $513.20M | $508.00M | $571.89M | $517.07M | $572.64M | $677.29M | $698.57M | $662.85M |
| QoQ Change | — | -3.8% | +22.7% | -8.7% | +2.0% | -3.3% | +16.2% | -7.0% | +9.3% | -7.4% | +23.1% | -15.2% | +12.7% | -1.0% | +12.6% | -9.6% | +10.7% | +18.3% | +3.1% | -5.1% |
| YoY Change | — | — | — | — | +9.9% | +10.4% | +4.5% | +6.5% | +14.1% | +9.3% | +15.8% | +5.6% | +8.9% | +16.4% | +6.5% | +13.6% | +11.6% | +33.3% | +22.1% | +28.2% |